Lima, Peru Clinical Trials

A listing of Lima, Peru clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 104 clinical trials
Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infections

This study will assess the safety and efficacy of cefepime/VNRX-5133 compared with meropenem in both eradication of bacteria and in symptomatic response in patients with cUTIs.

pyelonephritis
acute pyelonephritis
cefepime
meropenem
Site 160410
 (0.7 away) Contact site
  • 145 views
  • 28 Jun, 2021
  • +102 other locations
Evaluation of Efficacy and Safety of Pamrevlumab in Patients With Idiopathic Pulmonary Fibrosis

This is a Phase 3 trial to evaluate the efficacy and safety of 30 mg/kg intravenous (IV) infusions of pamrevlumab administered every 3 weeks as compared to placebo in subjects with Idiopathic Pulmonary Fibrosis

pamrevlumab
pirfenidone
nintedanib
idiopathic pulmonary fibrosis
carbon monoxide
Hospital Nacional Cayetano Heredia / Servicio de Inmunolog a y Reumatolog a
 (1.5 away) Contact site
  • 349 views
  • 16 Sep, 2021
  • +227 other locations
Efficacy Safety and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to <2 Years (MK-8616-169)

This study will evaluate the efficacy, safety, and pharmacokinetics (PK) of sugammadex (MK-8616) for reversal of both moderate and deep neuromuscular blockade (NMB) in pediatric participants aged birth to <2 years. The primary hypothesis of this study is that sugammadex is superior to neostigmine in reversing moderate NMB as measured …

rocuronium
intubation
neostigmine
glycopyrrolate
vecuronium
Instituto Nacional Cardiovascular Incor ( Site 3928)
 (2.2 away) Contact site
  • 4 views
  • 15 Sep, 2021
  • +37 other locations
A Study to Determine the Efficacy Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) Metronidazole (MTZ) Versus Meropenem (MER) Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.

A Phase 3 comparative study to determine the efficacy, safety and tolerability of Aztreonam-Avibactam (ATM-AVI) Metronidazole (MTZ) versus Meropenem (MER) Colistin (COL) for the treatment of serious infections due to Gram negative bacteria.

meropenem
metronidazole
colistin
chest x-ray
antibiotics
Clinica Internacional - Unidad de Investigacion de la Clinica Internacional
 (0.8 away) Contact site
  • 190 views
  • 16 Sep, 2021
  • +189 other locations
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

This is a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL112 on reducing the risk of major adverse CV events [MACE - cardiovascular (CV) death, myocardial infarction (MI), and stroke] in subjects with acute coronary syndrome (ACS) diagnosed with either ST-segment elevation …

acute coronary syndrome
stroke
infarct
arterial disease
percutaneous coronary intervention
6040038 - Hospital Nacional Dos de Mayo
 (2.0 away) Contact site
  • 1131 views
  • 15 Sep, 2021
  • +3432 other locations
Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss

The purpose of this study is to determine whether treatment with alpelisib in combination with nab-paclitaxel is safe and effective in subjects with advanced triple negative breast cancer (aTNBC) who carry either a PIK3CA mutation (Study Part A) or have PTEN loss (Study Part B1) or PTEN loss without PIK3CA …

PTEN
cancer
breast cancer
measurable disease
paclitaxel
Novartis Investigative Site
 (5.9 away) Contact site
  • 5 views
  • 15 Sep, 2021
  • +153 other locations
Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

The purpose of this study is to assess the efficacy and safety of pembrolizumab in combination with concurrent chemoradiation therapy followed by either pembrolizumab with olaparib placebo (Arm 1) or with olaparib (Arm 2) compared to concurrent chemoradiation therapy followed by durvalumab (Arm 3) in participants with unresectable, locally advanced …

cancer
olaparib
platinum doublet
measurable disease
pemetrexed
Hospital Nacional Cayetano Heredia ( Site 0602)
 (1.5 away) Contact site
  • 51 views
  • 12 Sep, 2021
  • +191 other locations
Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042)

The purpose of this study is to evaluate the efficacy and safety of gefapixant, in improving symptoms of cough-induced stress urinary incontinence (SUI) in adult female participants with refractory or unexplained chronic cough. The primary hypothesis is that gefapixant is superior to placebo in reducing the frequency of cough-induced SUI …

gefapixant
refractory chronic cough
unexplained chronic cough
chest radiograph
Hospital Nacional Arzobispo Loayza ( Site 0607)
 (0.8 away) Contact site
  • 88 views
  • 15 Sep, 2021
  • +89 other locations
Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab

The purpose of this extension study is to establish efficacy and safety of ligelizumab. This will be assessed in adult and adolescent chronic spontaneous urticaria (CSU) patients who have completed a preceding ligelizumab study and have relapsed, following treatment in these preceding studies, despite standard of care H1-antihistamine (H1-AH) treatment. …

urticaria
antihistamines
ligelizumab
Novartis Investigative Site
 (4.9 away) Contact site
  • 1 views
  • 29 Aug, 2021
  • +229 other locations
Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation

Interventional, randomized, double-blind, placebo-controlled study encompassing 2 development phases (Phase 2 and Phase 3).

covid-19
mechanical ventilation
pneumonia
SARS
chest x-ray
Hospital Arzobispo Loayza
 (0.8 away) Contact site
  • 122 views
  • 17 Mar, 2021
  • +32 other locations